Smart-Money SignalNeutral · 50/100— Insider open-market flow is flat over 90 days
Revenue$422.0K
Net Income-$15.0M
EPS$-0.11
Gross Margin97.4%
Market Cap$1.3B
Price Performance
Historical data including institutional events
Company Profile
I
Iain Ross
CEO & Executive Director
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London.
